Showing results (261-270 of 330) with videos related to
Sort By:
Pageof 33
Clinical Colorectal Cancer|December 14, 2017
Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal CarcinomaRasmus Sönnichsen, Laura Hennig, Vera Blaschke, et al.The Lancet. Oncology|November 28, 2009
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trialGunnar Folprecht, Thomas Gruenberger, Wolf O Bechstein, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 10, 2026
FRUQUITAS trial: Study design of an ENGIC intergroup randomized phase III of trifluridine/tipiracil +/- fruquintinib in pre-treated metastatic gastro-oesophageal adenocarcinomaDavid Tougeron, Fernando Rivera, Tania Fleitas Kanonnikoff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2024
Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV TrialsNuh N Rahbari, Sebastiano Biondo, Ricardo Frago, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 8, 2021
Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort studyJonas Kuon, Miriam Blasi, Laura Unsöld, et al.Annals of Surgical Oncology|May 4, 2011
Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancerKatja Ott, Ken Herrmann, Tibor Schuster, et al.European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancerFlorian Lordick, Theo Ruers, Daniela E Aust, et al.Medical Oncology (Northwood, London, England)|June 27, 2014
Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS studyJalid Sehouli, Klaus Pietzner, Pauline Wimberger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ StudyIvonne Haffner, Katrin Schierle, Elba Raimúndez, et al.The Oncologist|April 21, 2017
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV StudyChiara Alessandra Cella, Giovanni Di Minno, Chiara Carlomagno, et al.Pageof 33